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Poster Session I S235be a consideration in the pre-transplant evaluation. Studies are
needed to further delineate the immunologic impact of donor
serostatus.220
CMV SPECIFIC T CELLS PREVENT PROGRESSION FROM LOW TO HIGH
LEVEL VIREMIA IN D1R1 BUT NOT D-R1 PATIENTS
Hoegh-Petersen, M.1, Roa, L.1, Liu, Y.1, Zhou, F.1, Ugarte-Torres, A.1,
Louie, P.1, Fonseca, K.2, Khan, F.1, Storek, J.1 1University of Calgary,
Calgary, AB, Canada; 2Alberta Health Services, Calgary, AB, Canada
Background:Cytomegalovirus (CMV) reactivates (becomes detect-
able in blood) in most seropositive hematopoietic cell transplant
(HCT) recipients. In some reactivating patients, low level viremia
(\ 50,000 DNA copies/ml plasma, ie, less than our institutional
threshold for preemtive therapy) progresses to high level viremia
or CMV disease, which is potentially fatal. We hypothesized that
low level viremia progresses in patients with low specific T cell
counts and spontaneously resolves in patients with high specific T
cell counts.
Methods: In 30 CMV seropositive HCT recipients monitored
weekly for reactivation by real-time PCR, blood was drawn for
specific T cell counts within 4 days from the first episode of
low level viremia. Fourteen patients received grafts from seropos-
itive donors (D1R1), and 16 patients from seronegative donors
(D-R1). Mononuclear cells were stimulated overnight with
CMV lysate, pp65 overlapping peptides, no stimulus (negative
control) or staphylococcal enterotoxin B (positive control). T cells
producing IFNg, TNFa and/or IL2 were enumerated by flow cy-
tometry.
Results: Among D1R1 patients, counts of CMV lysate and pp65
specific CD4 T cells producing IFNg and TNFa (and not IL2)
were higher in patients with spontaneous resolution than patients
with progression (p 5 0.02 for CMV lysate, p 5 0.004 for pp65).
Also, there was an inverse correlation between pp65 specific CD8
T cells producing IFNg and TNFa and peak viremia (r 5 -0.94, p
5 0.005) in D1R1 patients who progressed to high level viremia/
disease. In contrast, among D-R1 patients, CMV lysate and pp65
specific T cell counts were similar in patients with spontaneous res-
olution and patients with progression, and there was no correlation
between specific T cell counts and peak viremia.
Conclusion:CMV specific T cells play a role in preventing progres-
sion from low to high level CMV reactivation/disease in D1R1
patients. Other immune mechanisms (eg, NK cells?) play the role
in D-R1 patients.221
ASSESSMENT OF IMMATURE RETICULOCYTE FRACTION AS AN EARLY
PREDICTOR OF MARROW ENGRAFTMENT AFTER HEMATOPOIECTIC
STEM CELL TRANSPLANTATION
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Introduction: Hematopoietic stem cell transplantation (HSCT)
has been used as a treatment for hematologic malignancies and
non-malignant disorders. The success of engraftment is important
for determining the direction of treatment and the prognosis
of patients. Various methods of early assessment have been
proposed. The purpose of this study was to evaluate immature
reticulocyte fraction (IRF) as an early predictor of marrow
engraftment and to validate cut-off values for IRF in pediatric
patients.
Patients and Methods: Retrospective analysis was performed on
172 patients including 108 males (62.8%) and 64 females
(37.2%) with a median age of 8.3 years who underwent HSCT
(autologous: 87 patients, allogeneic: 85 patients) in Seoul Na-
tional University Children’s hospital from January 1st, 2005 toDecember 31st, 2008. Complete blood counts with reticulocyte
parameters were measured in all patients. The day of engraftment
of neutrophil was defined as the first of three consecutive days of
an absolute neutrophil count . 500 /mL with GCSF support. En-
graftment of platelets was defined as an unsupported platelet
count over 20,000/mL for seven days.
Results: Standard neutrophil engraftment occurred after a mean of
12.164.3 days following HSCT and platelet engraftment occurred
after a mean of 19.4611.7 days. With regards to IRF, mean rates
were as follows: above 1% after 9.662.6 days, above 3.5% after
10.563.0 days, and above 5% after 11.163.6 days. These differences
was statistically significanct for IRF and platelets when compared
with standard neutrophil recovery after HSCT. Following HSCT,
themean day on which IRF increased above 3.5% preceded the stan-
dard neutrophil engraftment day (P\0.001). The predicting cut-off
value of IRF was 3.5% (AUC 5 0.879, 95% CI, 0.759-0.999) at 8
days after HSCT. Sensitivity and specificity were 86.7% and
82.8%, respectively.
Conclusions: Considering these results of the increase in IRF
preceded that of absolute neutrophil count (ANC) or platelets
in most cases, IRF was useful as an early indicator of marrow en-
graftment especially when observed simultaneously with the other
parameters.222
EXTRATHYMIC SITES DRIVE THYMUS-INDEPENDENT DEVELOPMENT OF
FUNCTIONAL T CELLS AFTER BONE MARROW TRANSPLANTATION
Holland, A.M.1,2, Zakrzewski, J.L.1, Fletcher, A.L.3, Smith, O.M.1,
Suh, D.1, King, C.G.1, Yim, N.L.1, Rao, U.K.1, Brill, J.1, van den
Brink, M.R.1 1Memorial Sloan-Kettering Cancer Center; 2Weill Cornell
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T cell deficiency after bone marrow transplantation (BMT) leads
to significant morbidity andmortality due to infection andmalignant
relapse. We have previously shown that CD4-CD8- T cell precur-
sors (preT) generated via OP9-DL1 coculture improve thymic and
peripheral T cell reconstitution when administered at the time of
BMT. While the thymus supports T cell development into old
age, adult BMT recipients have limited thymic function due to
age-related involution and additional injury caused by transplant
conditioning. We therefore hypothesized that T cell reconstitution
after BMT may depend to some extent on extrathymic T cell
development, which has previously been described as present but
abnormal.
We found that, in addition to the thymus, preT cells engrafted in
extrathymic sites, including mesenteric lymph nodes (MLN), pe-
ripheral lymph nodes (PLN) and spleen, within 24 hours of transfer
into euthymic BMT recipients. We detected CD41CD81 (double
positive, DP) thymocyte-like cells of both preT and bone marrow
(BM) origin in MLN, but not PLN, BM, or spleen, suggesting T
cell development in MLN. Using a novel dual reporter for biolumi-
nescence imaging we confirmed that preT trafficked to gut-associ-
ated tissues, where they underwent NFAT activation, consistent
with T cell development. In competitive reconstitution studies we
found that engraftment of preT in thymic and extrathymic sites re-
quired PSGL-1, while CCR9 may be dispensable.
To better study extrathymic T cell development, we transferred
preT into thymectomized or athymic BMT recipients. We demon-
strated that preT and BM cells develop into both TCRab and
TCRgd T cells in athymic BMT recipients. As in euthymic recipi-
ents, preT engraft in extrathymic gut-associated sites andMLN sup-
port DP early after transfer into athymic BMT recipients.We found
more CD41, CD8ab1, and CD8aa1 T cells in the spleen, PLN,
MLN, and Peyer’s patches of athymic BMT recipients that received
preT than in nontransplanted or BM only recipients. Extrathymic-
derived CD41 and CD8ab1T cells are naive CD44- cells with a di-
verse T cell receptor (TCR) repertoire. In addition, extrathymic-de-
rivedT cells proliferated to a similar extent as thymic-derived T cells
and produced IFNg and TNFa following in vitro stimulation. In
conclusion, using adoptively transferred preT, we have
S236 Poster Session Idemonstrated that extrathymic T cell development occurs in BMT
recipients, especially MLN, and results in functional T cells with
a broad TCR repertoire.223
FLT-3 LIGAND ENHANCES THYMOPOIESIS IN HEMATOPOIETIC STEM
CELL TRANSPLANTS (HSCT) INVOLVING AGED DONOR AND RECIPIENT
MICE BY INCREASING SURVIVAL AND TRAFFICKING OF EARLY THYMO-
CYTE PROGENITORS
Williams, K.M., Moore, A.R., Gress, R.E. National Institutes of Health,
Bethesda, MD
Impaired thymopoiesis may contribute to graft-versus-host dis-
ease and poor clearance of infections. Early thymic precursor fre-
quency is a point of regulation for thymus reconstitution;
however, it is unknown if decreased thymus recovery with age is
due to the absence of thymus elements or marrow precursors.
To address this, we investigated whether marrow thymus precur-
sor frequency declines with age, contributes to poor aged thymus
recovery, and can be enhanced with FMS-like tyrosine kinase 3
(Flt-3), a growth factor for HSC. Total number of HSC (LSK,
Lineage- Sca-11 and cKit1) and Flt-3R1 LSK were equivalent
in the marrow of old (. 4 months) and young mice (1 month).
By ELISA, marrow concentration of Flt-3L was equivalent be-
tween old and young mice. Similarly, there was no difference in
splenic LSK numbers. However, the response to exogenous Flt-
3L was distinct by age. While young marrow was unaffected after
Flt-3L, in aged mice, total LSK and CCR91 thymus directed
LSK increased 4 fold (p\ 0.05). The proportion of LSK that ex-
pressed Flt-3R decreased in the marrow of older mice in response
to Flt3-L and LSK proliferation (Ki67 and BrdU) did not differ in
response to Flt3-L in old or young mice, consistent with im-
proved survival rather than proliferation. We then hypothesized
that Flt-3L treated cells may also traffic to peripheral spaces, sim-
ilar to GCSF. Consistent with this theory, in the spleen of old and
young mice, the Flt3-R1 LSK number increased in response to
Flt3-L (p \ 0.05). We then used aged Flt3-L knock-out mice
(Flt3-L2/2) to test whether survival and trafficking were part
of the mechanism of Flt3-L. Aged Flt3-L 2/2 mice had signifi-
cantly lower LSK and Flt3-R1 LSK in the marrow than wild
type aged counterparts, consistent with a deficient survival signal.
After Flt3-L exposure, although Flt3-R proportion was un-
changed in the marrow, LSK numbers increased significantly in
the spleen (p\ 0.05) with equivalent Ki67, suggesting LSK traf-
ficked from marrow to spleen. Aged donor Flt3-L treated marrow
with lupron-treated aged host increased donor thymocytes two-
fold within 5 weeks after transplantation (p \ 0.05) compared
to lupron alone. Collectively, these data suggest that marrow
LSK milieu contributes to thymus dysfunction in older donor/
host recipient pairs and that Flt-3L may improve thymus recovery
by enhancing survival and trafficking of older donor HSC.224
CD31CD41 AND CD31CD81-LYMPHOCYTES AS BIOMARKERS PRE-
DICTING THE LONG TERM OUTCOME OF PEDIATRIC HAEMATOPOIETIC
STEM CELL TRANSPLANTATION RECIPIENTS
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Pagter, A.J.1, Egberts, A.C.G.1,2, Boelens, J.J.1 1UniversityMedical Cen-
ter Utrecht, Utrecht, Netherlands; 2Utrecht University, Utrecht, Nether-
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Introduction: Haematopoietic stem cell transplantation (HSCT)
may be complicated by severe infectious complications, graft-ver-
sus-host disease (GvHD) and relapse/graft failures the probability
thereof depends on the lymphocyte immune reconstitution. The
goal of this study was to identify biomarkers of immune reconstitu-
tion in the first period after transplantation that may predict
outcome.Methods: Children transplanted between 2005-2007 in the
UMCU were prospectively included. Immunophenotyping was
performed every two weeks after HSCT. Several parameters of
immune reconstitution in relation with survival, acute- and
chronic-GvHD were studied, using a multiplicative intensity
model in R: AUC, the time and maximum CD31CD41,
CD31CD81 T-cell and CD191B-cell numbers, the ratio be-
tween CD4/CD8 and the relationship between naive and memory
cells in the period 0-90,0-180 and 180-360 days. Data were strat-
ified to donor source. Relations were tested in linear, logaritmic
and parabolar functions. The differences between models were
compared using the P-values and diagnostics of the model. Based
on the resulting model, we defined a cut off value to describe op-
timal survival per biomarker.
Results: 56 recipients received bone marrow, 12 received a sibling
donor, while 26 patients received cord blood derived stem cells.
The median age at HSCT was 5.9 years (range 0.11 – 18.1).
The max nr of CD41 cells related to their age related reference
values in the first 6 months after HSCT positively predicted sur-
vival (HR 0.43, CI95% 0.29-0.63), with a cutoff point of 0.15. In
Cord blood transplants the CD4/8 ratio within the first half year
. 5 was a predictor for survival (HR 5 0.6 CI95% 0.40-0.91).
In BM/sibling transplants, the maximum number of CD8 cells
related to their age related reference values . 1 positively pre-
dicted survival within the first half year (HR 5 0.68, CI95%
0.46-1.01).
Conclusion: CD31CD41 and CD31CD81 divided by their age
related reference values, predicted outcome early after HSCT in
children and may be used in future studies and in clinical practice,
after further validation of these relationships.225
IMMUNE RECONSTITUTION IN HEMATOPOIETIC CELL TRANSPLANTA-
TION PATIENTS RECEIVING ATG AS PART OF CONDITIONING REGIME
Hoegh-Petersen, M., Dhadda, M., Liu, Y., Hagel, L., Podgorny, P.J.,
Ugarte-Torres, A., Storek, J. University of Calgary, Calgary, AB, Canada
Introduction: Successful immunological recovery in recipients of
hematopoietic cell transplantation (HCT) is important for trans-
plant success. Use of anti-thymocyte globulin (ATG) as part of
the pre-transplant conditioning has shown to decrease graft versus
host disease (GvHD). However the impact of ATG on immuno-
logical recovery has not been studied. Here we studied the factors
influencing immune cell recovery after ATG-conditioned HCT.
Patients and Methods: Immune subsets were quantified in 176 al-
logeneic HCT recipients receiving ATG during conditioning, at day
28, 56, 84, 180, 365 and 730 post transplantation. Following lym-
phocyte subsets were quantified: B cells, CD4 T cells and CD8 T
cells (incl. their naive and memory/effector [mem/eff] subsets), NK
cells (incl. regulatory and cytolytic subsets), monocytes and dendritic
cells (DC) (incl. plasmacytoid and myeloid subsets). Day 7 serum
levels of ATGwere quantified by flow cytometry. Significance of as-
sociations between immune cell subset counts and factors suspected
to influence themwere tested usingMann-Whitney rank sum test for
categorical factors and Spearman rank correlation test for continu-
ous variable/factors.
Results: Higher recipient age was associated with lower na€ıve
CD4 and CD8 T cell counts on days 180, 365 and 730. Graft con-
tent of specific subsets positively correlated with counts of the
same subset early posttransplant in the case of B cells (both naive
and memory), CD4 and CD8 T cells (both naive and mem/eff),
and myeloid DCs. Significant GvHD (grade 2-4 acute or moder-
ate-severe chronic) was associated with significantly lower B cell
counts (including naive and memory) on days 56-180, regulatory
NK cells on days 28-56, plasmacytoid DCs on day 28-84 and
higher counts of naive CD8 T cells on days 28-84. High day 7 se-
rum ATG levels were associated with decreased CD4 and CD8 T
cell counts and increased regulatory NK cell counts early, but for
most subsets not late posttransplant. Graft CD34 cell count and
recipient CMV serostatus showed no positive correlation with
any immune cell subset count.
